NYMOX PHARMACEUTICAL CORP (NYMX) has 91 open-market insider trades by 4 insiders since 2015. The most active filer is James George Robinson, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| James George Robinson | Dir | — | 86 | $7.9M | 2023-04-27 |
| Paul Averback | CEO | — | 2 | $4.4M | 2018-10-29 |
| Erik Danielsen | CFO | — | 2 | $16K | 2018-12-21 |
| Randall J. Lanham | General Counsel | — | 1 | $5K | 2018-10-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| James George Robinson | Director & 10% | Buy | $37K | 2023-04-25 |
| James George Robinson | Director | Buy | $3.8M | 2022-05-02 |
| James George Robinson | Director | Buy | $83K | 2021-04-21 |
| James George Robinson | Director | Buy | $12K | 2019-07-10 |
| James George Robinson | Director | Buy | $11K | 2019-07-09 |
| James George Robinson | Director | Buy | $13K |
Companies that share insiders with NYMX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2019-07-05 |
| James George Robinson | Director | Buy | $12K | 2019-07-03 |
| James George Robinson | Director | Buy | $13K | 2019-07-01 |
| James George Robinson | Director | Buy | $152K | 2019-06-28 |
| James George Robinson | Director | Buy | $14K | 2019-06-27 |
| James George Robinson | Director | Buy | $14K | 2019-06-26 |
| James George Robinson | Director | Buy | $16K | 2019-06-25 |
| James George Robinson | Director | Buy | $16K | 2019-06-20 |
| James George Robinson | Director | Buy | $14K | 2019-06-19 |
| James George Robinson | Director | Buy | $15K | 2019-06-18 |